In the US, Bortezomib (bortezomib systemic) is a member of the drug class miscellaneous antineoplastics and is used to treat Lymphoma and Multiple Myeloma.
US matches:
- Bortezomib
- Bortezomib Intravenous
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
L01XX32
CAS registry number (Chemical Abstracts Service)
0179324-69-7
Chemical Formula
C19-H25-B-N4-O4
Molecular Weight
384
Therapeutic Category
Antineoplastic agent
Chemical Names
{(1R)-3-methyl-1-[(2S)-3-phenyl-2-(pyrazin-2-carboxamido)propanamido]butyl}boronic acid (WHO)
Boronic acid, [(1R)-3-methyl-1-[[(2S)-1-oxo-3-phenyl-2[(pyrazinylcarbonyl)amino]propyl]amino]butyl]- (USAN)
N-[(1S)-1-benzyl-2-{[(1R)-1-(dihydroxyboranyl)-3-methylbutyl]-amino}-2-oxoethyl]- pyrazinecarboxamid (IUPAC)
Foreign Names
- Bortezomibum (Latin)
- Bortezomib (German)
- Bortézomib (French)
- Bortezomib (Spanish)
Generic Names
- Bortezomib (OS: BAN, USAN)
- LDP-341 (IS)
- MG 341 (IS)
- MLN-341 (IS)
- NSC 681239 (IS)
- PS-341 (IS)
Brand Names
- Velcade
Ben Venue, China; Ben Venue, Oman; Janssen, Antigua & Barbuda; Janssen, Netherlands Antilles; Janssen, Argentina; Janssen, Australia; Janssen, Aruba; Janssen, Barbados; Janssen, Belgium; Janssen, Bermuda; Janssen, Bahamas; Janssen, Colombia; Janssen, Czech Republic; Janssen, Germany; Janssen, Ecuador; Janssen, Spain; Janssen, Finland; Janssen, Grenada; Janssen, Guyana; Janssen, Hong Kong; Janssen, Hungary; Janssen, Israel; Janssen, Iceland; Janssen, Italy; Janssen, Jamaica; Janssen, Cayman Islands; Janssen, Saint Lucia; Janssen, Luxembourg; Janssen, Mexico; Janssen, Netherlands; Janssen, Norway; Janssen, New Zealand; Janssen, Philippines; Janssen, Poland; Janssen, Romania; Janssen, Serbia; Janssen, Russian Federation; Janssen, Slovenia; Janssen, Slovakia; Janssen, Suriname; Janssen, Thailand; Janssen, Trinidad & Tobago; Janssen, Taiwan; Janssen, Saint Vincent & The Grenadines; Janssen, Venezuela; Janssen Pharmaceutical K.K., Japan; Janssen-Cilag, Austria; Janssen-Cilag, Switzerland; Janssen-Cilag, Chile; Janssen-Cilag, Denmark; Janssen-Cilag, France; Janssen-Cilag, Indonesia; Janssen-Cilag, Turkey; Janssen-Cilag, Vietnam; Janssen-Cilag, South Africa; Janssen-Ortho Inc., Canada; Johnson & Johnson, Croatia (Hrvatska); Millennium, United States; Ortho Biotech, United Kingdom - VELCADE
Janssen-Cilag, Sweden
International Drug Name Search
Glossary
BAN | British Approved Name |
IUPAC | International Union of Pure and Applied Chemistry |
IS | Inofficial Synonym |
OS | Official Synonym |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
USAN | United States Adopted Name |
WHO | World Health Organization |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment